Hydrogen sulfide (H 2S) has recently emerged as an important mediator of mammalian cardiovascular homeostasis. In nonmammalian vertebrates, little is known about the cardiac effects of H 2S. This study aimed to evaluate, in the avascular heart of the frog, Rana esculenta, whether and to what extent H 2S affects the cardiac performance, and what is the mechanism of action responsible for the observed effects. Results were analyzed in relation to those obtained in the rat heart, used as the mammalian model. Isolated and perfused (working and Langendorff) hearts, Western blot analysis, and modified biotin switch (S-sulfhydration) assay were used. In the frog heart, NaHS (used as H 2S donor, 10 Ϫ12 /10 Ϫ7 M) dose-dependently decreased inotropism. This effect was reduced by glibenclamide (K ATP channels blocker), 3-a]quinoxalin-1-one (guanylyl cyclase inhibitor), KT 5823 (PKG inhibitor), and it was blocked by Akt1/2 (Akt inhibitor) and by detergent Triton X-100. In the rat, in addition to the classic negative inotropic effect, NaHS (10 Ϫ12 /10 Ϫ7 M) exhibited negative lusitropism. In both frog and rat hearts, NaHS treatment induced Akt and eNOS phosphorylation and an increased cardiac protein S-sulfhydration that, in the rat heart, includes phospholamban. Our data suggest that H 2S represents a phylogenetically conserved cardioactive molecule. Results obtained on the rat heart extend the role of H 2S also to cardiac relaxation. H2S effects involve K ATP channels, the Akt/NOS-cGMP/PKG pathway, and S-sulfhydration of cardiac proteins. hydrogen sulfide; inotropism; lusitropism; nitric oxide synthasecGMP/PKG pathway HYDROGEN SULFIDE (H 2 S), AN endogenous signaling molecule, influences a wide range of physiological and pathological processes. First described as a physiological mediator in the brain (1) and then in the cardiovascular system (24), H 2 S quickly emerged as a cytoprotective molecule with effects on neurotransmission, neuroprotection, insulin release, inflammation, vessel motility, and cardioprotection (51). Along with nitric oxide (NO) and carbon monoxide (CO), it is now recognized as the third endogenous gasotransmitter (20, 48, 49) . In mammals, H 2 S is produced via the cysteine metabolic enzymes cystathionine ␤-synthase (CBS), cystathionine ␥-lyase (CSE) (1, 24), and the combined actions of cysteine aminotransferase and 3-mercaptopyruvate sulfurtransferase (42, 43) . CBS predominates in the brain, while CSE is the major H 2 S-producing enzyme in the cardiovascular system, where it is present in both vascular smooth muscle and endothelium (24, 52).
In all vertebrates, H 2 S was suggested to act as an oxygen sensor, being possibly involved in vascular responses to changes in oxygen availability. During normoxia, cytosolic H 2 S biosynthesis is counteracted by mitochondrial H 2 S oxidation. In contrast, during hypoxia, the low oxygen levels allow vascular H 2 S accumulation, thus modulating the vascular tone (35, 38) .
The cardiovascular role of H 2 S is well documented in mammals. H 2 S-induced vasodilation of mammalian systemic vessels was first described in 1997 (24) . H 2 S produces a dose-dependent relaxation of arteries and veins in vitro, and a reduction of blood pressure in vivo (56, 57) . In both rat and human blood vessels, one of the most important sites of action of H 2 S is the ATP-sensitive K ϩ channel (K ATP ), which causes hyperpolarization and relaxation (50, 56) . Via K ATP channel activation, H 2 S shortens action potential duration (2) and cardioprotects against ischemia and reperfusion injury (7, 39, 40, 53, 55) . Moreover, H 2 S depresses heart contractility by inhibiting the ␤-adrenergic system (53) and the intracellular calcium handling (46) .
A cross-talk between NO and H 2 S has been documented, although their interaction is waiting to be fully defined. H 2 S has been reported to either enhance (24) or reduce (56) the relaxant effect of NO in the rat aorta, while NO enhanced H 2 S release in rat vascular tissues, also increasing CSE expression in cultured vascular smooth muscle cells (57) . It has been also suggested that low H 2 S concentrations produce a slight vasoconstriction either by removing the tonic NO-mediated vasodilation (4), or by directly inhibiting endothelial NO synthase (26) , or by reacting with NO to form an inactive nitrosothiol (50) . On the other hand, an increased NO production from eNOS through an Akt-dependent mechanism, was also reported after H 2 S exposure (41) .
In nonmammalian vertebrates, data regarding H 2 S mainly concern its vasoactive properties. All classes exhibit, both in vivo and in vitro, vasoconstrictory and vasodilatory responses to H 2 S. These responses are species-and vessel-specific and may depend on either duration or dose of exposure (18, 37, 45) .
In contrast, the cardiac effects of H 2 S in nonmammalian vertebrates remain almost unexplored and only limited to few in vivo studies, which provided conflicting results. In trout, intrabuccal H 2 S injection was found to induce bradycardia (36) , while in the turtle, vascular infusion of H 2 S causes a marked tachycardia (45) .
The purpose of the present study was to analyze the effects of H 2 S on the performance of the avascular heart of Rana esculenta and to compare them with those obtained on the rat heart, used as a mammalian prototype. The use of the rat heart also provided information on the modulation elicited by H 2 S on the diastolic function, an aspect so far neglected. In both models, attention was focused on the intracellular signaling involved in the H 2 S-dependent action, with particular reference to the interaction with the NO system. Finally, being that S-sulfhydration is an integrative mechanism induced by H 2 S, this posttranslation modification of cardiac proteins was also evaluated.
MATERIALS AND METHODS

Isolated Working Frog Heart
Specimens of frogs (R. esculenta) of both sexes, adult and sexually mature, weighing 16 -25 g, were provided by a local hatchery and kept at room temperature (18 -20°C) without feeding for 5-7 days. Hearts were isolated and connected to a perfusion apparatus as previously described (47) . Animal care and experiments were in accordance to the Italian law (DL 116, January 27, 1992), and the scientific project was supervised and approved by the local ethical committee. Experiments were performed at room temperature (18 -20°C) . Hearts were perfused with saline containing (in mM/l) 115 NaCl, 2.5 KCl, 1.0 CaCl 2, 2.15 Na2HPO4, 0.85 NaH2PO4, and 5.6 glucose. It was equilibrated with air, and pH was adjusted to 7.30 -7.35 by the addition of Na2HPO4.
Measurements and calculations. Output pressure (afterload) was set at 29.47 mmHg, and the input pressure (preload) was regulated by varying the height of the input reservoir to obtain a cardiac output of about 110 ml·min Ϫ1 ·kg body wt Ϫ1 . Both preload and afterload were within the physiological range. The heart generated its own rhythm. Hearts that did not stabilize within 10 -15 min from the onset of perfusion were discarded. Since cardiac parameters were stable for Ͼ1 h (21), experiments were carried out within this period. Pressures were measured through two MP-20D pressure transducers (Micron Instruments, Simi Valley, CA) connected to a PowerLab data acquisition system and analyzed using Chart software (ADInstruments, Ugo Basile, Comerio, Italy). Pressures (preload and afterload) were expressed in mmHg and corrected for cannula resistance. Afterload (mean aortic pressure) was calculated as 2/3 diastolic pressure ϩ 1/3 maximum pressure. Cardiac output was collected over 1 min and weighed; it was corrected for fluid density and expressed as volume measurement (ml/min) normalized to the wet body weight in kilograms. Stroke volume (SV; ml/kg; cardiac output/heart rate), was used as a measure of ventricular performance (i.e., index of inotropism). Ventricular stroke work [SW; mJ/g; (afterload-preload) ϫ SV/ventricle mass] served as an index of systolic functionality.
Langendorff-Perfused Rat Heart
Male Wistar rats (Harlan Laboratories, Udine, Italy), 12 wk old, weighing 180 -240 g were housed in a ventilated cage rack system under standard conditions. Animals had ad libitum food and water access. Animal care, euthanasia, and experiments were in accordance with the Guide for the Care and Use of Laboratory Animals (U.S. National Institutes of Health, publication no. 85-23, revised 1996; Italian law, DL 116, January 27, 1992). Rats were anesthetized by intraperitoneal injection of ethyl carbamate (2 g/kg body wt). Hearts were then dissected out, mounted on a Langendorff apparatus, and perfused with a Krebs-Henseleit solution, containing (in mM/l) 113 NaCl, 4.7 KCl, 25 NaHCO 3, 1.2 MgSO4, 1.8 CaCl2, 1.2 KH2PO4, 11 glucose, 1.1 mannitol, 5 Na-pyruvate (pH 7.4; 37°C; 95% O2-5% CO2), delivered at a constant flow rate of 12 ml/min (5) .
Measurements and calculations. To measure left ventricular pressure, a water-filled latex balloon, connected to a pressure transducer (BLPR; WRI, Sarasota, FL), was inserted through the mitral valve into the left ventricle to allow isovolumic contractions and to continuously record mechanical parameters. The balloon was progressively filled with water to obtain an initial left ventricular end diastolic pressure of 5 to 8 mmHg (5). Hemodynamic parameters were assessed using a PowerLab data acquisition system and analyzed using Chart software (ADInstruments, Basile, Italy). Heart performance was evaluated as 
Experimental Protocols
Drug application. After stabilization, both frog and rat hearts were perfused for 10 min with physiological solution enriched with increasing concentration of NaHS (from 10 Ϫ12 M to 10 Ϫ7 M) to generate cumulative concentration-response curves both in frog and rat hearts.
In the frog heart, the effects of NaHS (from 10 Ϫ11 M to 10 Ϫ8 M) were also tested after treatment with either glibenclamide (Gly, 10
or Triton X-100 (0.05%). Western blot analysis. Cardiac ventricles from rat and frog treated with NaHS (10 Ϫ9 M) were used to evaluate differences in both eNOS and Akt phosphorylation. In addition, in frog ventricles, eNOS phosphorylation was determined after treatment with either Triton X-100 alone or with NaHS (10 Ϫ9 M) plus Triton X-100, or with NaHS plus Akt1/2 (Akt inhibitor, 10 Ϫ7 M). Samples were homogenized in ice-cold RIPA buffer (Sigma Aldrich) containing a mixture of protease inhibitors (1 mmol/l aprotinin, 20 mmol/l phenylmethylsulfonyl fluoride, and 200 mmol/l sodium orthovanadate). Then homogenates were centrifuged at 200 g for 10 min at 4°C for debris removal. Protein concentration was determined using Bradford reagent, according to the manufacturer's recommendations (Sigma-Aldrich). Equal amounts of proteins were separated on 8% SDS-PAGE gels (for p-eNOS and eNOS detection, 60 g) or on 10% SDS-PAGE gels (for p-Akt and Akt detection, 40 g), transferred to PVDF membranes, blocked with nonfat-dried milk and incubated overnight at 4°C with a polyclonal rabbit anti-phospho-eNOS antibody (Ser-1177) or with a polyclonal rabbit anti-phospho-Akt antibody Ser-473 (Santa Cruz Biotechnology, DBA, Milan, Italy) diluted 1:1,000 in TBS-Tween containing 5% nonfat dry milk. The anti-rabbit peroxidase-linked secondary antibody (Santa Cruz Biotechnology) was diluted 1:2,000 in TBS-Tween containing 5% non-fat dry milk. Polyclonal rabbit anti-eNOS and anti-Akt were used as loading controls (Santa Cruz Biotechnology).
Modified biotin switch (S-sulfhydration) assay. The assay was carried out as previously described (25) , with modifications according to Mustafa et al. (32) . Untreated and NaHS-perfused rat and frog hearts were homogenized in HEN buffer [250 mM HEPES-NaOH (pH 7.7), 1 mM EDTA, and 0.1 mM neocuproine] supplemented with 100 M deferoxamine and centrifuged at 13,000 g for 30 min at 4°C. Ventricle homogenates were added to blocking buffer [HEN buffer adjusted to 2.5% SDS and 20 mM methyl methanethiosulfonate (MMTS)] at 50°C for 20 min with frequent vortexing. MMTS was removed by acetone, and the proteins were precipitated at Ϫ20°C for 20 min. After acetone removal, the proteins were resuspended in HENS buffer (HEN buffer adjusted to 1% SDS) and then incubated for 1 h at room temperature with biotin-HPDP in dimethyl sulfoxide without ascorbic acid, centifruged, and resuspended in HENS buffer. To detect biotinylated proteins, samples were separated on 10% SDS-PAGE gels, transferred to a PVDF membrane, blocked with nonfat dried milk, and incubated with streptavidin-peroxidase diluted 1:5,000 for 1 h.
Immunoprecipitation. To verify whether phospholamban (PLN) is a specific S-sulfhydration target of NaHS, an immunoprecipitation technique was used. Untreated and NaHS-perfused rat hearts were homogenized in lysis buffer and biotinylated, as described previously (12) . Equal amounts of each sample were incubated overnight at 4°C with a rabbit polyclonal anti-PLN antibody (FL-52; Santa Cruz Biotechnology). Proteins were then immunoprecipitated by Protein A/G PLUS-agarose (immunoprecipitation reagent; Santa Cruz Biotechnology). Immunoprecipitated proteins were washed three times with lysis buffer and subjected to Western blot analysis. Membranes, probed with the same rabbit polyclonal anti-PLN antibody and subsequently with a peroxidase-coupled anti-IgG secondary antibody, were revealed using the ECL system.
Immunodetection. For both Western blot and modified biotin switch assay, immunodetection was performed using an enhanced chemiluminescence kit (ECL PLUS, Amersham). Autoradiographs were obtained by exposure to X-ray films (Hyperfilm ECL, Amersham). Immunoblots were digitized, and the densitometric analysis of the bands was carried out using National Institutes of Health IMAGE 1.6 for a Macintosh computer based on 256 gray values (0 ϭ white; 256 ϭ black).
In additional experiments, the membrane for S-sulfhydration detection was stripped and reprobed using a rabbit polyclonal anti-PLN antibody (FL-52) (Santa Cruz Biotechnology).
Statistical Analysis
Data were expressed as means Ϯ SE of percentage changes obtained from individual experiments. Statistical analysis was determined by using one-or two-way ANOVA followed by Dunnett's or Bonferroni's post hoc tests. Differences were considered statistically significant at P Ͻ 0.05. GraphPad Prism software, version 4 (GraphPad Software, San Diego, CA) was used for all of the statistical analysis.
RESULTS
Basal Conditions
The in vitro isolated and perfused frog heart generates cardiac hemodynamic responses that mimic those obtained in vivo. After 10 -15 min of stabilization, the following basal values were obtained: SV ϭ 1.61 Ϯ 0.1 ml/kg; SW ϭ 3.65 Ϯ 0.35 mJ/g; HR ϭ 59.6 Ϯ 1.8 beat/min; preload ϭ 0.97 Ϯ 0.22 mmHg; afterload ϭ 28.57 Ϯ 0.3 mmHg; cardiac output ϭ 108.5 Ϯ 2.3 ml·min Ϫ1 ·kg Ϫ1 . In the Langendorff perfused rat heart preparation, basal cardiac parameters, obtained after 20 min equilibration, were LVP ϭ 89 Ϯ 3 mmHg; HR ϭ 280 Ϯ 7 bpm; ϩ (LVdP/dt)max ϭ 2,492 Ϯ 129 mmHg/s; Ϫ (LVdP/dt)max ϭ Ϫ1,663 Ϯ 70 mmHg/s; HTR ϭ 0.05 Ϯ 0.01 s; T/-t ϭ Ϫ1.49 Ϯ 1.84 mmHg/s; pressure perfusion ϭ 100 mmHg; CP ϭ 63 Ϯ 3 mmHg. Endurance and stability of the preparations, analyzed by measuring the performance variables every 10 min, showed that each heart was stable up to 180 min.
Effects of NaHS on Frog and Rat Basal Cardiac Performance
In the frog heart, NaHS (from 10 Ϫ12 M to 10 Ϫ7 M) induced a concentration-dependent negative inotropic effect, revealed by the significant reduction of SV and SW starting from 10 Ϫ12 M (Fig. 1A) . No changes in heart rate were observed (data not shown).
In the rat heart, NaHS (from 10 Ϫ12 M to 10 Ϫ7 M) induced negative inotropism, revealed by the reduction of LVP and ϩ(LVdP/dt)max, and negative lusitropism, showed by the significant reduction of Ϫ(LVdP/dt)max and HTR and by the increment of T/-t (Fig. 1B) without changing HR (data not shown). NaHS also induced vasodilation, as indicated by the CP reduction observed at all concentrations tested (data not shown).
H 2 S Mechanism of Action
Frog heart. In a second series of experiments, concentrationresponse curves of NaHS (10 Ϫ11 -10 Ϫ8 M) were performed to investigate, in the frog heart, the mechanism underlying the negative inotropism of H 2 S.
INVOLVEMENT OF ATP-DEPENDENT K-CHANNELS (KATP). K ATP channels are presented in the myocardium in all vertebrates (30) . In the mammalian heart, their activation mediates a negative inotropic effect (22) and protects against ischemic/ reperfusion injury (23) . In the frog heart, K ATP channels inhibition by glibenclamide (10 Ϫ7 M), reduced the negative inotropism of NaHS of about 50% (Fig. 2A) . Glibenclamide per se did not affect cardiac parameters (16) .
INVOLVEMENT OF THE NITRIC OXIDE PATHWAY. There is evidence that H 2 S may interact with the NO transduction pathway (24) . To investigate whether this pathway is involved in the negative inotropism mediated by NaHS, frog cardiac preparations were treated with either NOS (L-NMMA; 10 Ϫ5 M), or guanylyl cyclase (ODQ; 10 Ϫ5 M), or PKG (KT 5823 , 10 Ϫ7 M) inhibitors. All treatments significantly reduced the concentration-dependent NaHS effects of about 50%. (Fig. 2B) . In the avascular frog heart, a constitutive endothelial NOS (eNOS), restricted to endocardial endothelium (EE) cells, was first documented by us (47) and was further corroborated by the presence of the activated eNOS (3), thus supporting the idea that in this heart the EE represents the source of paracrine NO release. Consistent with these data, in the present study, the functional damage of EE by Triton X-100 (0.05%) resulted in a complete inhibition of NaHS-induced effects at all concentrations tested, implicating an EE-mediated mechanism in H 2 S signaling (Fig. 2C) .
Akt, a serine/threonine protein kinase activated in a phosphatidylinositol-3 kinase (PI3-K)-dependent manner, can directly phosphorylate and activate eNOS at Ser-1177 (as target downstream) (17) . In the frog heart, Akt pharmacological inhibition blocked the negative effects of NaHS, suggesting an Akt-dependent NO production (Fig. 2C) . L-NMMA, ODQ, and Triton X-100 per se significantly increased SV (29, 40, 42) ; KT 5823 (26) and Akt1/2 (data not shown) per se did not modify cardiac parameters.
Frog and rat hearts. P-ENOS AND P-AKT EXPRESSION. The phosphorylation state of Akt (p-Akt) and eNOS (p-eNOS) was assessed by Western blots in the frog and rat hearts after treatment with NaHS (10 Ϫ9 M). Results showed a significant increase of p-Akt and p-eNOS consistent with an Akt-dependent eNOS activation (Fig. 3, A and B) . In the frog heart, the pretreatment with both Akt inhibitor (Akt1/2) and Triton X-100 blocked increment of eNOS phosphorylation induced by NaHS. Triton X-100 alone also abolished the p-eNOS increase, thus confirming the EE as the principal source of NO generation (Fig. 3A) .
Proteins S-Sulfhydration
It is known that H 2 S physiologically modifies cysteines by S-sulfhydration, which represents a posttranslational protein modification (32, 33) . A modified biotin switch method was used to analyze the pattern of S-sulfhydration of cytosolic and membrane proteins of control and NaHS-treated hearts. Results indicated that in the frog heart, H 2 S generation induced an increase of S-sulfhydration of high-and low-molecular weight cytosolic proteins (Fig. 4A) . In the rat, NaHS exposure induced an increase of S-sulfhydration of both cytosolic and membrane proteins (Fig. 4B) . The range of S-sulfhydrated proteins appeared to include the band corresponding to the regulatory protein PLN that, by modulating intracellular calcium cycling, is involved in the myocardial relaxation. Western blot analysis of membrane fraction revealed two bands corresponding to the apparent molecular weights of PLN monomer (6 kDa) and dimer (12 kDa) as putative targets for S-sulfhydration (Fig.  4B ). This was confirmed by immunoprecipitation of the membrane protein fraction with anti-PLN antibody on both control and NaHS-treated hearts. Densitometric analysis of the bands corresponding to 6 and 12 kDa revealed an increased PLN S-sulfhydration in NaHS-treated hearts, which was particularly evident in the case of the 12-kDa band (Fig. 4C) .
DISCUSSION
H 2 S, together with NO and CO, belongs to the family of the gaseous transmitters that, as largely shown in mammals, are involved in cardiovascular control under both physiological and pathological conditions. In mammals, H 2 S is active on the vessels in which it regulates the vascular tone, as well as on the , ratio between maximal LV contraction rate and maximal LV relaxation rate (T/-t) in isolated and perfused Langendorff rat heart (B). Percentage changes were evaluated as means Ϯ SE (n ϭ 6). *P Ͻ 0.05, significant difference from control values (one-way ANOVA followed by Dunnett's post hoc test).
heart, in which it inhibits contractility, also playing cardioprotection (27) . Interestingly, evidence indicates that also in each class of nonmammalian vertebrates, H 2 S has both vasodilatory and vasoconstrictory properties (18) . However, it is unknown whether and to what extent, as in mammals, it is able to affect also the performance of the nonmammalian heart. The purpose of the present study was to analyze the effect of H 2 S and its mechanism of action on the isolated working heart of the frog R. esculenta, and to compare these effects with those obtained on the rat heart, used as a mammalian prototype. In particular, on the rat heart, the effects of H 2 S were also evaluated in relation to the diastolic function, an aspect, which so far has been neglected. Results show that, as in mammals, also in frog, H 2 S induced negative inotropism. In the rat, this effect is accompanied by a negative modulation of relaxation. We also observed that H 2 S-dependent effects involve K ATP channels, the Akt/NOS-cGMP/PKG pathway, and S-sulfhydration of cardiac proteins.
H 2 S Effects in Frog and Rat Heart
In the frog heart, NaHS induced a concentration-dependent negative inotropic effect, as indicated by the decrement of about 40% of SV and SW observed at the highest concentration. Because the frog heart is characterized by the absence of a coronary vessel supply, the H 2 S-mediated inhibition of contractility is obtained via a direct action on the myocardium. To the best of our knowledge, this observation represents the first evidence of a direct action of H 2 S on a whole nonmammalian heart. In fact, only a NaHS-induced reduction of contraction is reported on isolated myocardial strips from frog ventricles (44) .
The H 2 S-mediated negative inotropism was also observed in Langendorff perfused rat hearts exposed to NaHS, in which H 2 S generation induced negative inotropic effects shown by the reduced LVP and ϩ(LVdP/dt)max. These data are in agreement with the H 2 S-dependent depression of contractility already reported (22) . Interestingly, regardless of the different ventricular myoarchitecture and intracardiac blood supply, in both the avascular (frog) and the richly vascularized (rat) heart, H 2 S exerts a negative inotropic influence.
Of note, in the rat, NaHS administration induced a dosedependent inhibition of cardiac relaxation, as indicated by the reduction of Ϫ(LVdP/dt)max, significant at all concentrations tested, with a decrease of about 50% at higher concentrations. In addition, NaHS reduced HTR, an index of contraction-relaxation coupling, used to simultaneously evaluate variations in contraction and relaxation and to quantify drug-induced changes in myocardial lusitropy (8) . This is of note since the shorter time needed to reach the 50% of LVP decline, suggests, for the first time, a negative lusitropic control elicited by H 2 S. Thus, as demonstrated for NO (8), H 2 S would function as a "protective" mechanism, which contributes to the normal cardiac function.
Mechanism of Action
K ATP channels. In mammals, both vessel relaxation and negative inotropic effects of H 2 S are reported to occur through 2 . A: effects of NaHS (10 Ϫ11 -10 Ϫ8 M) before and after treatment with Gly (10 Ϫ7 M) on SV in isolated and perfused frog hearts. Percentage changes were evaluated as means Ϯ SE. Differences are indicated as *P Ͻ 0.05 (NaHS vs. control; n ϭ 6) and #P Ͻ 0.05 (NaHS vs. Gly alone; n ϭ 5) (one-way ANOVA followed by Dunnett's post hoc test); §P Ͻ 0.05 (NaHS alone vs. NaHSϩGly; n ϭ 5) (two-way ANOVA followed by Bonferroni's post hoc test). B: effects of NaHS (10 Ϫ11 -10 Ϫ8 M) before and after treatment with either
Ϫ5 M), or KT5823 (10 Ϫ7 M) on stroke volume (SV) in isolated and perfused frog hearts. Percentage changes were evaluated as means Ϯ SE. Differences are indicated as *P Ͻ 0.05 (NaHS vs. control; n ϭ 6) and #P Ͻ 0.05 (NaHS vs. inhibitors; n ϭ 5-7) (one-way ANOVA followed by Dunnett's post hoc test); §P Ͻ 0.05 (NaHS vs. NaHSϩinhibitors) (two-way ANOVA followed by Bonferroni's post hoc test). C: effects of NaHS (10 Ϫ11 -10 Ϫ8 M), before and after treatment with Triton X-100 (0.05%) or Akt1/2 (10 Ϫ7 M) on SV in isolated and perfused frog hearts. Percentage changes were evaluated as means Ϯ SE. Differences are indicated as *P Ͻ 0.05 (NaHS vs. control; n ϭ 6) (one-way ANOVA followed by Dunnett's post hoc test); §P Ͻ 0.05 (NaHS vs. NaHSϩTriton or NaHS vs. NaHSϩAkt1/2; n ϭ 4 for each group) (two-way ANOVA followed by Bonferroni's post hoc test).
K ATP channel activation (22, 57) . K ATP channels, discovered by Noma (34) in cardiac myocytes, are modulated by intracellular ATP concentration and are inhibited by glibenclamide.
They are usually open and leak potassium under conditions when cellular energy demand exceeds energy supply, for example during hypoxia or ischemia. In nonmammalian vertebrates, including amphibians, previous studies have demonstrated the presence of cardiac glibenclamide binding sites, suggesting that K ATP channels may be involved in the adaptation to hypoxia (30) . In our work, we found that in the frog heart, NaHS-induced negative inotropism was attenuated by K ATP channels block with glibenclamide, suggesting that these channels are partially involved in mediating the cardioinhibition elicited by H 2 S. This agrees with the partial contribution of K ATP channels in H 2 S-dependent response, already documented in the mammalian heart (22) . Our data lead us to hypothesize that, as in mammals, other signal pathways have to be recruited by H 2 S to depress frog myocardial contractility.
NO pathway. An exciting aspect of H 2 S bioactivity is its interaction with NO. In isolated rat aorta H 2 S enhances NOmediated relaxation (24) , reduces blood pressure in rats with hypertension induced by NOS inhibition, and mediates cardioprotection through NOS activation (53) .
We demonstrated that in the frog heart the cardiosuppressive action of NaHS involves the NOS/NO system. NOS inhibition by L-NMMA attenuated NaHS-negative inotropism, suggesting that an endogenous NO production is required for H 2 Sdependent effects. We also found that pharmacological inhibition of both guanylyl cyclase (ODQ) and PKG (KT 5823 ) reduced the NaHS-dependent effects. An involvement of the cGMP/PKG pathway downstream in the H 2 S mechanism of action in mammalian vascular system has been documented (9, 10, 15) . Thus, in the frog heart, like NO, H 2 S may converge on PKG as the final effector.
Notably, H 2 S interacts with the NO system also via stimulation of Akt-dependent eNOS phosphorylation. This agrees with the literature, which proposed Akt as the site of interaction between H 2 S and NO (11, 41) . In addition, since NaHSdependent Akt phosphorylation was abolished by either wortmannin or LY 294002, it has been suggested that PI3K acts as an upstream regulator of Akt upon H 2 S stimulation (11) . However, the mechanism by which a gas like hydrogen sulfide activates eNOS remains unknown. In our study, an increased phosphorylation of both Akt (Ser-493) and eNOS (Ser-1177) was observed in both frog and rat hearts after NaHS treatment. In addition, in the frog heart, the pharmacological inhibition of Akt prevented the p-eNOS increment, confirming the role of H 2 S in enhancing NO production via Akt/eNOS activation.
In the avascular frog heart, the identification of p-eNOS, prevalently localized at endocardial level (3), supported the notion that in the frog heart the EE represents the principal source of paracrine NO, which modulates the contractile performance of the subjacent myocardium under basal and chemically stimulated conditions. No discernible nNOS immunoreactivity either in myocardiocytes or in EE was revealed (3).
Consistent with these data, we found that NaHS-induced negative inotropism was abolished by the functional damage of the EE by Triton X-100. This treatment also prevents the increase of p-eNOS expression induced by NaHS, thus suggesting that the functional integrity of the EE/eNOS system is required for H 2 S signaling. Our hypothesis is supported by the results of previous works, which reported that either the block of endogenous NO production, or the physical removal of the endothelium, or eNOS gene deletion attenuates H 2 S-induced vasorelaxation (15, 57) . In addition, eNOS-deficient mice were found to lack the beneficial effects of H 2 S during cardiac arrest (31).
Protein S-Sulfhydration
One of the key mechanisms involved in the H 2 S cardiac effects is protein S-sulfhydration, which, by converting cysteine -SH groups to -SSH, regulates the function of many proteins, including ␤-tubulin, actin, and glyceraldehyde 3-phosphate dehydrogenase, and K ATP channels (32, 33) . Thus, similar to the NOinduced S-nitrosylation, S-sulfhydration is an important signaling mechanism that modulates many biological processes. Our data revealed that in both frog and rat heart, NaHS treatment increases cytosolic protein S-sulfhydration. Therefore, we hypothesized that this posttranslational modification may be an additive mechanism involved in H 2 S-dependent control of cardiac function. Western blot and biotin switch techniques revealed in rat cardiac homogenates the S-sulfhydration of proteins corresponding to the apparent molecular weight of PLN. This protein is a key regulator of cardiac contractility and relaxation, since it modulates Ca 2ϩ uptake into SR through SR Ca 2ϩ -ATPase (SERCA2a) (13) . Recently, Chen and coworkers (14) showed that endogenous H 2 S contributes to inactivate SERCA2a pump, and thus SR Ca 2ϩ uptake through PLN dephosphorylation. Our previous studies have demonstrated an important role of PLN in the lusitropic action of several cardioactive substances, such as catestatin and 17-␤-estradiol through both phosphorylation and S-nytrosylation mechanism (5, 6, 19) . Together with the literature data, we suggested PLN S-sulfhydration as an alternative mechanism for SERCA2a regulation, with putative consequences on the H 2 S-dependent negative inotropic and lusitropic actions. The hypothesis of PLN S-sulfhydration by H 2 S was confirmed by immunoprecipitation studies, which revealed a band of about 12 kDa corresponding to the molecular mass of PLN dimer.
In conclusion, the present study documented for the first time in the avascular frog heart a negative inotropic effect of H 2 S, which involves Akt-dependent eNOS activation and the cGMP/PKG pathway, also revealing the obligatory role of EE in transducing H 2 S activity. Our results are of interest since they show that, in the mammalian heart, in addition to the depression of contractility, H 2 S is able to elicit negative lusitropism, with consequent effects on diastolic filling. The observed protein S-sulfhydration suggested that, along with AKT/eNOS/cGMP/PKG pathway, H 2 S may signal via this posttranslation modification, to elicit its effects in both frog and rat hearts. Further investigation will be required to identify other molecular targets of S-sulfhydration, in addition to PLN, which may play a role in the H 2 S-dependent cardiac effects.
Perspectives and Significance
The demonstration that, in both nonmammalian and mammalian vertebrates, H 2 S modulates the cardiac function, provides further evidence concerning its phylogenetically conserved versatile role as a cardioactive molecule. We demonstrated for the first time the responsiveness of the frog heart to H 2 S and the interplay of this gas with the NO pathway. Our results also provide novel insight into the role of H 2 S-dependent S-sulfhydration with particular reference to PLN S-sulfhydration, as an alternative mechanism for SERCA2a regulation. On the whole, our data confirm H 2 S as an important member of the complex scenario of gaseous signaling molecules that, like NO, contributes to cardiac homeostasis in different classes of vertebrates.
